Corvus Pharmaceuticals (CRVS) Q3 2025 Earnings

Aug 7Confirmed
Q3 2024
Q4 2024
Q2 2025
Q3 2025
-0.6
-0.42
-0.25
-0.07

Details

Expected EPS
-0.133333
Actual EPS
-0.1
Surprise EPS
0.03
Surprise Percent
+25%

Description

⁨Corvus Pharmaceuticals⁩ (⁦CRVS⁩) has reported earnings of ⁦-0.1⁩ per share for ⁦Q3 2025⁩.

0 Comments

Share your thoughts